Metabolic, Weight Loss & GLP-1
Retatrutide
A triple agonist targeting GLP-1, GIP, and glucagon receptors for potentially superior weight loss outcomes.
About Retatrutide
A triple agonist targeting GLP-1, GIP, and glucagon receptors for potentially superior weight loss outcomes.
About this entry
No editorial update date is available for this legacy overview. No independent clinical review has been performed.
